Most compounded Tirzepatide comes in 5mg, 10mg, or 15mg vials
Target dose: 4 to 6 grams daily, split into two or three doses
Your healthcare provider will have to inform Cigna that you have performed behavioral modifications (e.g., increasing exercise) and a reduced-calorie diet for at least three months, and have either: A BMI of 30 or higher, or A BMI of 27 or higher, plus a weight-related comorbidity approved by Cigna, such as hypertension, Type 2 diabetes, dyslipidemia (high cholesterol), obstructive sleep apnea, or cardiovascular disease Wegovy is also FDA approved for cardiovascular risk reduction
The best approach aligns with the individuals journey and provides flexibility
IGFBP escape The distinctive trait of IGF-1 LR3 is its capacity to escape IGFBP sequestration